• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Fluor Corporation (Amendment)

    2/14/23 1:31:32 PM ET
    $FLR
    Military/Government/Technical
    Industrials
    Get the next $FLR alert in real time by email
    SC 13G/A 1 FLR13g01.txt FLUOR CORP. AMENDMENT 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.1) FLUOR CORP (Name of Issuer) Common Shares (Title of Class of Securities) 343412102 (CUSIP Number) Hotchkis and Wiley Capital Management, LLC 601 S. Figueroa Street 39th Fl, Los Angeles, CA 90017 213-430-1897 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 31, 2022 (Date of Event which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |X| Rule 13d-1(b) | | Rule 13d-1(c) | | Rule 13d-1(d) CUSIP No. 343412102 -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON Hotchkis and Wiley Capital Management, LLC S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 95-4871957 -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)|_| Joint filing (b)| | -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER 4,077,588 SHARES BENEFICIALLY ---------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER 0 EACH REPORTING ---------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER 4,312,188 WITH ---------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,312,188 shares (Ownership disclaimed pursuant to Section 13d-4 of the 1934 Act) -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ___ -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.03% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON IA -------------------------------------------------------------------------------- Item 1(a). Name of Issuer: FLUOR CORP Item 1(b). Address of Issuer's Principal Executive Offices: 6700 Las Colinas Blvd. Irving, TX 75039 Item 2(a). Name of Person Filing: Hotchkis and Wiley Capital Management, LLC Item 2(b). Address of Principal Business Office or, if none, Residence: 601 S. Figueroa Street 39th Fl, Los Angeles, CA 90017 Item 2(c). Citizenship: Delaware Item 2(d). Title of Class of Securities: Common Shares Item 2(e). CUSIP Number: 343412102 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a)/ / Broker or dealer registered under Section 15 of the Exchange Act. (b)/ / Bank as defined in Section 3(a)(6) of the Exchange Act. (c)/ / Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d)/ / Investment company registered under Section 8 of the Investment Company Act. (as to 2(a)(b) above) (e)/X/ An investment adviser in accordance with Rule 13d-1(b)(1)(ii) (E). (as to 2(a)(a) above) (f)/ / An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g)/ / A parent holding company or control person in accordance with Rule 13d-1(b)(ii)(G). (h)/ / A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i)/ / A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j)/ / Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4(a). Amount beneficially owned: 4,312,188 (Ownership disclaimed pursuant to Section 13d-4 of the 1934 Act) Item 4(b). Percent of class: 3.03% Item 4(c). Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 4,077,588 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 4,312,188 (iii) Shared power to dispose or to direct the disposition of: 0 Note that certain of HWCM's clients have retained voting power over the Common Shares that they beneficially own. Accordingly, HWCM has the power to dispose of more Common Shares than it can vote. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X] Item 6. Ownership of More than Five Percent on Behalf of Another Person [] Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2023 Signature: /s/ Tina H. Kodama Name/Title: Tina H. Kodama Chief Compliance Officer
    Get the next $FLR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FLR

    DatePrice TargetRatingAnalyst
    12/18/2024$54.00 → $58.00Outperform → Neutral
    Robert W. Baird
    10/22/2024$52.00 → $65.00Neutral → Buy
    Citigroup
    7/17/2024$57.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/14/2024$46.00Buy
    Truist
    1/10/2024Sector Weight
    KeyBanc Capital Markets
    10/4/2023$35.00 → $47.00Neutral → Buy
    UBS
    11/7/2022$25.00 → $40.00Neutral → Buy
    DA Davidson
    2/23/2022$30.00 → $29.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $FLR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification

      Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs Fluor Corporation (NYSE:FLR) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519864245/en/Bayer's Cell T

      5/19/25 7:19:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor Reports First Quarter 2025 Results

      "Grow and execute" chapter of Fluor's strategy launched Q1 revenue book to burn ratio of 1.5x Accelerated Q1 share repurchases of $142 million; targeting $600 million in repurchases for 2025 Company maintains 2025 guidance Fluor Corporation (NYSE:FLR) announced financial results for its first quarter ended March 31, 2025. "We are well positioned for the grow and execute chapter of our Building a Better Future strategy. As we continue to deliver on our projects and take in quality backlog, we see substantial opportunities for growth in our key markets. Our businesses are focused on organic growth and our core competencies will deliver results that support our customers' needs," sai

      5/2/25 5:50:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor to Participate in Upcoming Investor Conferences

      Fluor Corporation (NYSE:FLR) announced today that management will be hosting one on one meetings at the following conferences for the second quarter of 2025: May 8: Truist Securities Industrials & Services Conference – John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. May 28: KeyBanc Industrials & Basic Materials Conference - Jim Breuer, Chief Executive Officer will be joining John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. June 4: Baird Global Consumer, Technology & Services Conference – Steve Hopkins, Sr. Vice President of Advanced Technologies & Life Sciences will be joining Jason Landkamer, Vic

      4/30/25 8:00:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    SEC Filings

    See more
    • Fluor Corporation filed SEC Form 8-K: Leadership Update

      8-K - FLUOR CORP (0001124198) (Filer)

      6/24/25 5:04:39 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • SEC Form SD filed by Fluor Corporation

      SD - FLUOR CORP (0001124198) (Filer)

      6/2/25 4:34:19 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Fluor Corporation

      SCHEDULE 13G/A - FLUOR CORP (0001124198) (Subject)

      5/12/25 10:44:45 AM ET
      $FLR
      Military/Government/Technical
      Industrials